Why Did PFSA Stock Surge 80% Pre-Market Today?

Shares of Profusa, Inc. (PFSA) surged more than 80% in pre-market trading on Monday after the company announced plans to enter the molecular diagnostics space through a proposed acquisition of the PanOmics diagnostic platform from BioInsights.

Under the agreement, Profusa would gain exclusive rights to the PanOmics platform and related expertise, including access to samples and tools, from BioInsights, for about $30 million. The consideration is payable in equity, the firm stated.

BioInsights will receive a 3% royalty on future net revenue. The move is expected to add to Profusa’s real-time biochemistry monitoring technology.

Get updates to this developing story on Stocktwits.

For updates and corrections, email newsroom[at]stocktwits[dot]com.